OBJECTIVE: We evaluated the relationship between various risk scores (SYNTAX score [SS], SYNTAX score-II [SS-II], thrombolysis in myocardial infarction [TIMI] risk scores, and Global Registry of Acute Coronary Events [GRACE] risk scores) and major adverse cardiovascular events (MACE) in non-ST elevation myocardial infarction (NSTEMI) patients undergoing percutaneous coronary intervention (PCI). SUBJECTS AND METHODS: The study population were selected from among 589 patients who underwent coronary angiography with a diagnosis of NSTEMI. TIMI and GRACE risk scores were calculated. SS and SS-II were calculated in all patients, and points were added according to the predefined algorithm, taking into account the other 6 clinical variables being monitored (age, sex, left ventricular ejection fraction, creatinine clearance, chronic obstructive pulmonary disease, and peripheral artery disease). Patients were classified into tertile 1 (SS < 22), tertile 2 (SS 23-32), and tertile 3 (SS > 32). RESULTS: The group with high SS-II for PCI values in the risk scores were observed from tertile 1 to tertile 3 (from 25.0 ± 7.7 to 31.6 ± 9.4, p < 0.001, respectively). The SS-II score in patients with PCI was an independent predictor of MACE, in-hospital mortality, nonfatal myocardial infarction, and stent thrombosis (OR 1.082, 95% CI 1.036-1.131, p < 0.001). The overall MACE, in-hospital mortality, and nonfatal myocardial infarction rates were significantly higher in the high SS-II for PCI group (p < 0.001). CONCLUSION: TIMI and GRACE risk scores were able to predict MACE. In addition to these, SS-II was also able to predict in-hospital mortality, nonfatal myocardial infarction, and stent thrombosis.
OBJECTIVE: We evaluated the relationship between various risk scores (SYNTAX score [SS], SYNTAX score-II [SS-II], thrombolysis in myocardial infarction [TIMI] risk scores, and Global Registry of Acute Coronary Events [GRACE] risk scores) and major adverse cardiovascular events (MACE) in non-ST elevation myocardial infarction (NSTEMI) patients undergoing percutaneous coronary intervention (PCI). SUBJECTS AND METHODS: The study population were selected from among 589 patients who underwent coronary angiography with a diagnosis of NSTEMI. TIMI and GRACE risk scores were calculated. SS and SS-II were calculated in all patients, and points were added according to the predefined algorithm, taking into account the other 6 clinical variables being monitored (age, sex, left ventricular ejection fraction, creatinine clearance, chronic obstructive pulmonary disease, and peripheral artery disease). Patients were classified into tertile 1 (SS < 22), tertile 2 (SS 23-32), and tertile 3 (SS > 32). RESULTS: The group with high SS-II for PCI values in the risk scores were observed from tertile 1 to tertile 3 (from 25.0 ± 7.7 to 31.6 ± 9.4, p < 0.001, respectively). The SS-II score in patients with PCI was an independent predictor of MACE, in-hospital mortality, nonfatal myocardial infarction, and stent thrombosis (OR 1.082, 95% CI 1.036-1.131, p < 0.001). The overall MACE, in-hospital mortality, and nonfatal myocardial infarction rates were significantly higher in the high SS-II for PCI group (p < 0.001). CONCLUSION: TIMI and GRACE risk scores were able to predict MACE. In addition to these, SS-II was also able to predict in-hospital mortality, nonfatal myocardial infarction, and stent thrombosis.
Authors: E M Antman; M Cohen; P J Bernink; C H McCabe; T Horacek; G Papuchis; B Mautner; R Corbalan; D Radley; E Braunwald Journal: JAMA Date: 2000-08-16 Impact factor: 56.272
Authors: Andrew T Yan; Raymond T Yan; Mary Tan; Amparo Casanova; Marino Labinaz; Kumar Sridhar; David H Fitchett; Anatoly Langer; Shaun G Goodman Journal: Eur Heart J Date: 2007-04-16 Impact factor: 29.983
Authors: Vasim Farooq; Chrysafios Girasis; Michael Magro; Yoshinobu Onuma; Marie Angèle Morel; Jung Ho Heo; Hector Garcia-Garcia; Arie Pieter Kappetein; Marcel van den Brand; David R Holmes; Michael Mack; Ted Feldman; Antonio Colombo; Elisabeth Ståhle; Stefan James; Didier Carrié; Gerard Fournial; Gerrit-Anne van Es; Keith D Dawkins; Friedrich W Mohr; Marie-Claude Morice; Patrick W Serruys Journal: EuroIntervention Date: 2013-03 Impact factor: 6.534
Authors: Mandeep Singh; Charanjit S Rihal; Bernard J Gersh; Ryan J Lennon; Abhiram Prasad; Paul Sorajja; Rachel E Gullerud; David R Holmes Journal: Circulation Date: 2007-05-28 Impact factor: 29.690
Authors: Hakan Erkan; Gülhanım Kırış; Levent Korkmaz; Mustafa Tarık Ağaç; İsmail Gökhan Çavuşoğlu; İhsan Dursun; Ahmet Seyda Yılmaz; Ahmet Oğuz Aslan; Dilek Cahide Kırcı; Şükrü Çelik Journal: Med Princ Pract Date: 2015-07-09 Impact factor: 1.927
Authors: Carlos M Campos; David van Klaveren; Javaid Iqbal; Yoshinobu Onuma; Yao-Jun Zhang; Hector M Garcia-Garcia; Marie-Angele Morel; Vasim Farooq; Hiroki Shiomi; Yutaka Furukawa; Yoshihisa Nakagawa; Kazushige Kadota; Pedro A Lemos; Takeshi Kimura; Ewout W Steyerberg; Patrick W Serruys Journal: Circ J Date: 2014-07-07 Impact factor: 2.993
Authors: Cengiz Burak; Muhammed Süleymanoğlu; Mahmut Yesin; Murat Cap; İbrahim Yıldız; İbrahim Rencüzoğulları; Metin Çağdaş; Yavuz Karabağ; Şerif Hamideyin; Doğan İliş; Erkan Baysal Journal: Med Princ Pract Date: 2020-04-28 Impact factor: 1.927